COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

dc.contributor.authorDíez, Cristina
dc.contributor.authorDel Romero-Raposo, Jorge
dc.contributor.authorMican, Rafael
dc.contributor.authorLópez, Juan C.
dc.contributor.authorBlanco, José R.
dc.contributor.authorCalzado, Sonia
dc.contributor.authorSamperiz, Gloria
dc.contributor.authorPortilla, Joaquín
dc.contributor.authorGarcía-Fraile, Lucio J.
dc.contributor.authorGutiérrez, Félix
dc.contributor.authorGómez-Sirvent, Juan L.
dc.contributor.authorSuárez-García, Inés
dc.contributor.authorAmador, Concha
dc.contributor.authorNovella, María
dc.contributor.authorArribas, Jose R.
dc.contributor.authorMoreno, Santiago
dc.contributor.authorGonzález-García, Juan
dc.contributor.authorJarrín, Inmaculada
dc.contributor.authorBerenguer, Juan
dc.contributor.authorCervero, Miguel
dc.date.accessioned2025-11-19T08:53:11Z
dc.date.available2025-11-19T08:53:11Z
dc.date.created2021
dc.date.issued2021
dc.description.abstractObjectives: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID-19 with [people with HIV (PWH)] and without (non-PWH) HIV co-infection in Spain during the first wave of the pandemic. Methods: This was a retrospective matched cohort study. People with HIV were identi fied by reviewing clinical records and laboratory registries of 10 922 patients in active follow-up within the Spanish HIV Research Network (CoRIS) up to 30 June 2020. Each hospitalized PWH was matched with five non-PWH of the same age and sex randomly selected from COVID-19@Spain, a multicentre cohort of 4035 patients hospitalized with confirmed COVID-19. The main outcome was all-cause in-hospital mortality. Results: Forty-five PWH with PCR-confirmed COVID-19 were identified in CoRIS, 21 of whom were hospitalized. A total of 105 age/sex-matched controls were selected from the COVID-19@Spain cohort. The median age in both groups was 53 (Q1¿Q3, 46¿56) years, and 90.5% were men. In PWH, 19.1% were injecting drug users, 95.2% were on antiretroviral therapy, 94.4% had HIV-RNA < 50 copies/mL, and the median (Q1¿Q3) CD4 count was 595 (349¿798) cells/¿L. No statistically significant differ ences were found between PWH and non-PWH in number of comorbidities, pre senting signs and symptoms, laboratory parameters, radiology findings and severity scores on admission. Corticosteroids were administered to 33.3% and 27.4% of PWH and non-PWH, respectively (P = 0.580). Deaths during admission were documented in two (9.5%) PWH and 12 (11.4%) non-PWH (P = 0.800). Conclusions: Our findings suggest that well-controlled HIV infection does not modify the clinical presentation or worsen clinical outcomes of COVID-19 hospitalization.es_ES
dc.description.curso2021es_ES
dc.formatapplication/pdfes_ES
dc.identifier.dl2021
dc.identifier.locationN/Aes_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12080/50980
dc.languageenges_ES
dc.publisherWileyes_ES
dc.rightsCC-BY-NCes_ES
dc.rights.accessrightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.eses_ES
dc.sourceHIV Medicinees_ES
dc.titleCOVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched studyes_ES
dc.typeArtículoes_ES

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
COVID¿19 in hospitalized HIV¿positive and HIV¿negative patients A matched study.pdf
Size:
125.62 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.76 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections